Clinical Resources | Heart Rhythm Society

Clinical Resources

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application.

HRS Clinical Document Methodology

The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements.

2002 NASPE Position Statement: The Revised NASPE/BPEG Generic Code for Antibradycardia, Adaptive-Rate, and Multisite Pacing 

Device Therapy

February 1, 2002—This statement provides the revised NBG code, endorsed by the British Pacing and Electrophysiology Group (BPEG) and the North American Society of Pacing and Electrophysiology (NASPE). This statement is more compatible with contemporary and emerging pacing technology with particular attention to the issue of multisite pacing.

 This document was reaffirmed on March 15, 2023 and will be formally assessed again in 2028.

2001 NASPE Clinical Cardiac Electrophysiology Fellowship Teaching Objectives for the New Millennium


December 1, 2001—This position paper outlines the basic science, clinical components, and procedural aspects of electrophysiology and provides relevant references that can be used as an educational guide.

 This document has been retired and replaced by HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. See also 2017 ACC/HRS Lifelong Learning Statement for Clinical Cardiac Electrophysiology Specialists.

2001 ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation

HRS Endorsed / Affirmed
Atrial Arrhythmias

October 1, 2001—Atrial fibrillation (AF) is the most common sustained rhythm disturbance. AF is often associated with structural heart disease, but a substantial proportion of patients with AF have no detectable heart disease. Hemodynamic impairment and thromboembolic events related to AF result in significant morbidity, mortality, and cost. The goal of this document is to provide guidance for better management of this frequent and complex arrhythmia. The document was approved by the governing bodies of the ACC, AHA, and ESC and officially endorsed by NASPE.

 This document has been retired. See 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation and 2019 AHA/ACC/HRS Focused Update.

2001 The Role(s) of the Industry-Employed Allied Professional 

Allied Professional

March 1, 2001—The Ad Hoc NASPE/Industry Task Force developed this policy statement to clarify the role industry-employed allied professionals (IEAPs) should play in the clinical environment, with the objective of maintaining and improving high-quality and cost-effective care for patients with implanted cardiac rhythm devices.

 This document has been retired and replaced by 2008 Heart Rhythm Society Policy Statement Update: Recommendations on the Role of Industry-Employed Allied Professionals (IEAPs). 

1996 AHA/NASPE Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations

Device Therapy

September 1, 1996—Patients with arrhythmias may experience complete or partial loss of consciousness, and questions about activities that are safe for them arise every day.

 See 2007 Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations. A Medical/Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology."